Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
550studies shown
Showing 1-12 of 550
Behavioral study icon
RecruitingNCT06976697

Home-Based tDCS Treatment Of Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 22 Years to 70 Years
Countries
United States
Sponsor
Sooma Medical Inc
Condition
Depression
Device study icon
RecruitingNCT07217223

Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 85 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Depression
Drug study icon
RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 22 Years to 65 Years
Countries
United States
Sponsor
University of Texas at Austin
Condition
Depression
Drug study icon
RecruitingNCT07196501

Maintenance Effect of NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Australia, Canada, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT06966401

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Canada, in the United Kingdom, ...

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT06911112

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Lithuania, ...

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Bulgaria, Lithuania, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT06963021

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Canada, in the United Kingdom, ...

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT06786624

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Depression
Behavioral study icon
RecruitingNCT06793397

A Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in the United Kingdom, ...

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 85 Years
Countries
United States, Australia, United Kingdom, ...
Sponsor
Cybin IRL Limited
Condition
Depression
Drug study icon
RecruitingNCT07065240

SPT-300 (GlyphAllo) for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Czechia, ...

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Seaport Therapeutics
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.